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lateralis were lower and heart rate was higher in the caffeine 
condition when compared to placebo. However, caffeine 
did not reduce the peripheral and central fatigue induced by 
high-intensity cycling exercise in moderate hypoxia.
Conclusion The caffeine-induced improvement in time to 
exhaustion during high-intensity cycling exercise in moder-
ate hypoxia seems to be mediated by a reduction in percep-
tion of effort, which occurs despite no reduction in neuro-
muscular fatigue.
Keywords Altitude · Perception of effort · Central fatigue · 
Peripheral fatigue · Exercise performance
Abbreviation
ANOVA  Analysis of variance
BRUMS  Brunel mood scale
FIO2  Fraction inspired oxygen
HR  Heart rate
MVC  Maximal voluntary contraction
ƞP
2  Partial eta squared
PPO  Peak power output
RMS  Root-mean-square
RPE  Rating of perceived exertion
sEMG  Surface electromyographic signals
SpO2  Oxygen saturation
VAL  Voluntary activation level
VO2max  Maximal oxygen consumption
Introduction
It is well established that caffeine reduces perception of 
effort and improves performance during endurance exercise 
at sea level (reviewed in Graham 2001; Doherty and Smith 
2004, 2005; Goldstein et al. 2010), and a large proportion 
Abstract 
Purpose To investigate the effects of caffeine on perfor-
mance, neuromuscular fatigue and perception of effort dur-
ing high-intensity cycling exercise in moderate hypoxia.
Methods Seven adult male participants firstly underwent 
an incremental exercise test on a cycle ergometer in condi-
tions of acute normobaric hypoxia (fraction inspired oxy-
gen = 0.15) to establish peak power output (PPO). In the 
following two visits, they performed a time to exhaustion 
test (78 ± 3% PPO) in the same hypoxic conditions after 
caffeine ingestion (4 mg kg−1) and one after placebo inges-
tion in a double-blind, randomized, counterbalanced cross-
over design.
Results Caffeine significantly improved time to exhaustion 
by 12%. A significant decrease in subjective fatigue was 
found after caffeine consumption. Perception of effort and 
surface electromyographic signal amplitude of the vastus 
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of endurance athletes consume it before or during compe-
titions (Del Coso et al. 2011). Little is known, however, 
about the ergogenic effect of caffeine in conditions of 
hypoxia. This is surprising if we consider that some endur-
ance competitions are staged at high altitude (e.g., Tour de 
France) and hypoxia has a negative effect on endurance 
performance (reviewed in Amann and Calbet 2008). Physi-
cal endurance is also required by mountaineers and soldiers 
operating at high altitude. Therefore, a better understanding 
of the physiological, perceptual, and performance effects of 
caffeine during endurance exercise in hypoxic conditions is 
warranted.
To the best of our knowledge, only three investigations 
have been published on the effects of caffeine on endur-
ance performance in conditions of hypoxia (Berglund and 
Hemmingsson 1982; Fulco et al. 1994; Stadheim et al. 
2015). In the first of these three placebo-controlled stud-
ies, Berglund and Hemmingsson (1982) found that caf-
feine (6 mg kg−1) significantly improves performance in 
14 well-trained crosscountry skiers competing in a 21-km 
time trial at 2900 m above sea level. Subsequently, Fulco 
et al. (1994) confirmed the positive effect of caffeine 
(4 mg kg−1) on endurance performance in conditions of 
acute hypoxia (4300 m above sea level) by measuring a sig-
nificant improvement in time to exhaustion in eight young 
adults cycling at 80% of their altitude-specific maximal 
oxygen consumption (VO2max). More recently, Stadheim 
et al. (2015) tested 13 well-trained cross-country skiers at 
a simulated altitude of 2000 m above sea level, and found 
that caffeine (4.5 mg kg−1) significantly improves time to 
exhaustion while double poling at 90% of altitude-specific 
VO2max. However, no significant overall improvement in 
performance was found during an 8-km cross-country dou-
ble poling time trial.
The improvements in endurance performance observed 
in these studies were mainly explained in terms of the 
caffeine-induced reductions in perception of effort and 
pain (Berglund and Hemmingsson 1982; Fulco et al. 1994; 
Stadheim et al. 2015). However, we hypothesize that the 
ergogenic effect of caffeine in hypoxic conditions may 
also be associated with a reduction in the neuromuscular 
fatigue induced by endurance exercise. Indeed, hypoxia 
exacerbates both the central and peripheral fatigue induced 
by endurance exercise (Amann and Calbet 2008), while 
caffeine improves neuromuscular function (Kalmar and 
Cafarelli 2004; Tarnopolsky 2008; Tallis et al. 2015). Sev-
eral human experiments suggest that caffeine may offset 
central fatigue by increasing central nervous system (CNS) 
excitability and maximal voluntary activation (reviewed 
in Kalmar and Cafarelli, 2004), although more research 
is necessary to test this hypothesis (Gandevia and Taylor 
2006). With regard to peripheral fatigue, it is well estab-
lished that supraphysiological concentrations of caffeine 
can reduce fatigue in isolated skeletal muscles, and more 
recent in vitro studies suggest that physiological concen-
trations achievable by oral ingestion of caffeine may also 
directly potentiate skeletal muscle force, work and power 
(Tallis et al. 2015). For example, caffeine treatment of 70 
and 50 μM resulted in significant improvements in power 
output for both maximally activated mouse extensor digi-
torum longus (fast) and soleus (slow) muscles (Tallis et al. 
2012). In vivo, electrical stimulation studies demonstrate 
that caffeine can directly improve the contractile proper-
ties of fatigued muscles, most likely by potentiating cal-
cium release from the sarcoplasmic reticulum (Lopes 
et al. 1983; Tarnopolsky and Cupido 2000). Furthermore, 
in spinal cord-injured patients, caffeine improves time to 
exhaustion during electrical cycling even though there is no 
active involvement of the brain, no afferent feedback from 
leg muscle receptors, and the sympathetic nervous system 
response is not present (Mohr et al. 1998). This finding 
suggests that the ergogenic effect of caffeine may occur, at 
least in part, by its direct action on the active muscles.
A caffeine-induced reduction in neuromuscular fatigue 
may, in turn, explain at least some of the reduced percep-
tion of effort and improved endurance performance found 
after caffeine ingestion in previous hypoxic studies (Ber-
glund and Hemmingsson 1982; Fulco et al. 1994; Stadheim 
et al. 2015). In fact, there is mounting evidence that percep-
tion of effort is related to central motor command, i.e., the 
activity of premotor and motor areas of the cortex leading 
to voluntary muscle contractions (Marcora 2009; Smirmaul 
2012; DeMorree et al. 2012, 2014; Zénon et al. 2015). 
When the neuromuscular system is fatigued, central motor 
command has to be increased to continue exercising at the 
same absolute force/power output, leading to an increase 
in perception of effort and premature exhaustion (Marcora 
et al. 2008; DeMorree et al. 2012). Importantly, the posi-
tive effects of caffeine on the neuromuscular system may 
partially counteract these negative effects of neuromuscu-
lar fatigue by reducing the activity of premotor and motor 
areas of the cortex required for a given level of submaximal 
force production, resulting in a lower perception of effort 
(DeMorree et al. 2014).
The main purpose of this study was to investigate the 
effects of caffeine on neuromuscular fatigue, perception 
of effort and performance during high-intensity cycling 
exercise in conditions of moderate hypoxia equivalent to 
≈2500 m altitude. We hypothesize that caffeine ingestion 
reduces central and peripheral fatigue induced by high-
intensity cycling exercise in moderate hypoxia, lowers per-
ception of effort, and increases time to exhaustion.
29Eur J Appl Physiol (2017) 117:27–38 
1 3
Materials and methods
Participants and ethical approval
A statistical power analysis was performed (GPower 3.1) for 
sample size estimation based on the time to exhaustion data 
from a previous hypoxia study (Fulco et al. 1994). As this 
study did not present correlation values between conditions, 
a conservative value of 0.5 was used for the calculation. The 
projected sample size was N = 3 with an effect size of 3.68, 
two-tailed alpha = 0.05 and power = 0.80. Using a more 
conservative approach, with an effect size of 1.5, the pro-
jected sample size was N = 6. Thus, seven healthy recrea-
tionally active males (mean ± SD, age 29 ± 6 years, height 
179 ± 8 cm, weight 75 ± 8 kg, moderate caffeine consump-
tion of 143 ± 77 mg day−1, ranging from 49 to 233 mg day−1) 
were recruited for this study. Informed consent, which was 
approved by the Ethics Committee of the School of Sport and 
Exercise Sciences according to the standards set by the Dec-
laration of Helsinki, was obtained from all individual partici-
pants included in the study. All participants were lifelong sea 
level residents who had not been exposed to altitudes greater 
than 1.500 m for at least 6 months before the study.
Study design
For this study, we employed a double-blind, randomized 
and counterbalanced cross-over design. Participants vis-
ited the laboratory on three different occasions. During the 
first preliminary visit, participants performed an incremen-
tal exercise test in hypoxia and were familiarized with all 
procedures. During the second and third visit (experimen-
tal visits), participants performed neuromuscular tests, and 
exercised in hypoxia at a constant power output for 6 min 
(isotime) and then to exhaustion in either a caffeine or pla-
cebo condition. Hypoxia during exercise was achieved by 
filling douglas bags with a gas mixture (HYP-100, Hypox-
ico Inc., NY, USA) with fraction of inspired oxygen of 15% 
(FIO2 = 0.15). Participants then breathed hypoxic air from 
the douglas bags using a non-rebreather mask. A minimum 
of 48 h between visits was given and participants were 
instructed to refrain from the consumption of any substance 
containing caffeine/alcohol (24 h prior), to consume a light 
meal ≈2 h before each visit, as well as to avoid any physi-
cal exercise/effort 24 h before each visit. Participants were 
also asked to inform if they had any acute illness, injury or 
muscle soreness.
Procedures
On the first visit, participants completed the Physical 
Activity Readiness Questionnaire (PAR-Q) (Thomas et al. 
1992), a Caffeine Consumption Questionnaire (Landrum 
1992) and a VO2max Estimation Questionnaire (Bradshaw 
et al. 2005), and underwent anthropometric measurements. 
Immediately after a wash-in period of 5-min breathing 
hypoxic air, an incremental exercise test (3 min at 70 W 
followed by 1 min of rest and 25 + 25 W increments 
every minute) was performed in hypoxia until exhaustion 
[operationally defined as a pedal frequency of less than 
70 revolutions.min−1 (RPM) for more than 5 s despite 
strong verbal encouragement] on an electromagnetically 
braked cycle ergometer (Lode BV, Medical Technology, 
Groningen, The Netherlands) to measure peak power out-
put (PPO), which was calculated according to a published 
equation (Kuipers et al. 1985). Participants were instructed 
to maintain a pedal frequency of 70–75 rpm throughout the 
test. Before the incremental exercise test, the position on 
the cycle ergometer was adjusted for each participant, and 
settings were recorded so that they could be reproduced at 
each subsequent visit. Participants were also given stand-
ard instructions for overall perception of effort using the 
15-point rating of perceived exertion (RPE) scale (Borg 
1982) to be used during the the incremental exercise test 
and subsequent visits. After the incremental exercise test, 
participants were familiarized with the neuromuscular 
assessment procedures (see “Neuromuscular assessment” 
section) and cycled for ≈6 min at ≈80% of PPO to further 
adjust the power in which they would exercise during the 
6-min isotime period in the next two visits (see below).
During the second and third visits, participants were 
asked to fill a mood questionnaire (see “Psychological 
questionnaires” for details) and were given an opaque gela-
tin capsule containing either placebo (dried milk) (DeMor-
ree et al. 2014) or caffeine (4 mg kg−1). This caffeine dos-
age was used as dosages of 3 to 6 mg kg−1 are ergogenic, 
and to allow for better comparison with a previous study in 
hypoxia (Fulco et al. 1994). Treatment order was randomly 
allocated according to balanced permutations generated 
by a web-based computer program (http://www.randomi-
zation.com). After 40 min, to reduce instrumentation time 
after treatment, the electrodes used for the neuromuscular 
assessment procedures were placed on the participants. 
One hour after treatment, participants were asked to fill the 
mood questionnaire for a second time and a questionnaire 
on motivation related to the upcoming exercise task (see 
“Psychological questionnaires” for details). Participants 
were also asked to try to identify which treatment (i.e., 
caffeine or placebo) they were given, and then immedi-
ately started the testing protocol (Fig. 1). The exercise task 
consisted of: neuromuscular assessment at rest, a wash-in 
period of 5-min breathing hypoxic air, a 3-min warm-up 
cycling at 40% PPO, a fixed period of 6 min (isotime) of 
cycling exercise in hypoxia at 78 ± 3% PPO (216 ± 37 W), 
neuromuscular assessment 3 min after the end of the 6-min 
isotime period, 5-min rest followed by a wash-in period of 
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5-min breathing hypoxic air, time to exhaustion test cycling 
in hypoxia at ≈80% PPO (78 ± 3%; 216 ± 37 W), and 
neuromuscular assessment 3 min after the end of the time 
to exhaustion test. In both the 6-min isotime period and 
the time to exhaustion test, participants were instructed to 
maintain a pedal frequency of 70–75 rpm throughout the 
test, with exhaustion operationally defined as in the incre-
mental test with verbal encouragement given by a blinded 
investigator. Time to exhaustion was measured using a 
chronometer to the nearest 1.0 s, from the indication of 
the researcher to the participants to start pedaling until 
exhaustion.
Physiological and perceptual responses
At the end of warm-up, at the end of the 6-min isotime 
period and after the time to exhaustion test, a 20-µl sam-
ple of whole fresh blood was taken by pricking the partici-
pants’ right thumb and analyzed for lactate concentration 
(Super GL2, Dr. Müller Gerätebau, Germany). Lactate 
accumulation was calculated by subtracting the 6-min iso-
time period and exhaustion values by the sample value col-
lected at the end of the warm-up. Heart rate (HR) (Polar 
RS800CX, Polar Electro Oy, Kempele, Finland) and index 
finger oxygen saturation (SpO2) from pulse-oximetry 
(model 9500, Nonin Onyx, Plymouth, MN, USA) were 
recorded each minute during exercise. Also, during the final 
15 s of each minute of exercise, participants were asked to 
rate their overall perception of effort (as already described) 
on a large RPE scale displayed in front of them throughout 
the cycling tests. The same physiological and perceptual 
responses were measured during the preliminary incremen-
tal exercise test.
Psychological questionnaires
The Brunel Mood Scale (BRUMS) (Terry et al. 2003) was 
used to assess mood. This questionnaire, which is based on 
the Profile of Mood States, contains 24 items (e.g., angry, 
uncertain, miserable, tired, nervous, energetic) divided 
into six respective subscales: anger, confusion, depres-
sion, fatigue, tension, and vigor. The items are answered 
on a five-point Likert scale (0 = not at all, 1 = a little, 
2 = moderately, 3 = quite a bit, 4 = extremely), and each 
subscale, with four relevant items, can achieve a raw score 
in the range of 0–16. Of particular interest in the present 
study were the subscales for fatigue and vigor, which were 
measured before and 1 h after placebo or caffeine ingestion 
(before starting the exercise).
Motivation related to the upcoming exercise task was 
measured 1 h after placebo or caffeine ingestion using the 
success motivation and intrinsic motivation scales (Mat-
thews et al. 2001). Each scale consists of 7 items (e.g., “I 
want to succeed on the task” and “I am concerned about 
not doing as well as I can”) scored on a five-point Likert 
scale (0 = not at all, 1 = a little, 2 = moderately, 3 = quite 
a bit, 4 = extremely). Therefore, total scores for these moti-
vation scales range between 0 and 28.
Electromyographic recordings
Throughout the exercise task, the surface electromyo-
graphic signal (sEMG) was recorded from the right vastus 
lateralis muscle. Before placing the Ag/AgCl electrodes 
(Swaromed Universal, Nessler Medizintechnik, Innsbruck, 
Austria), the skin was shaved, cleaned with alcohol swabs 
and dried. Electrodes were placed following the SENIAM 
recommendations (Hermens et al. 2000). The reference 
electrode was placed at the patella of the same leg. The 
sEMG signal was amplified (MP150, Biopac Systems Inc., 
Santa Barbara, CA, USA) and a frequency band filter rang-
ing from 20 to 500 Hz was applied. The sEMG was digi-
tized with a sampling frequency of 2000 Hz and processed 
(AcqKnowledge 4.1.1 Software, Biopac Systems®, CA, 
USA) by calculating the root-mean-square (RMS) every 
minute (last 10 s) of the 6-min isotime period and at 25, 50, 
75 and 100% (windows of 10 s) of time to exhaustion for 
placebo, and the respective data points for caffeine. In addi-
tion, the exhaustion value for sEMG RMS was also calcu-
lated. These sEMG RMS values during the 6-min isotime 
Fig. 1  Illustration of the testing 
protocol during the experimen-
tal visits
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period and the time to exhaustion test were normalized 
to the value measured during the last 10 s of the preced-
ing 3-min warm-up.
Neuromuscular assessment
Unilateral maximal voluntary contraction (MVC) torque 
of the right-leg knee extensors was assessed in isometric 
condition at rest, 3 min after the end of the 6-min isotime 
period, and 3 min after the end of the time to exhaustion 
test. An isokinetic dynamometer (Cybex NORM®, Humac, 
CA, USA) was adjusted to position the knee joint at 75° of 
flexion (0° = leg fully extended) and hip joint at an angle 
of 90°. Initially, participants performed a warm-up that 
included ≈10 submaximal contractions of the knee exten-
sor muscles, and was performed only before the stimula-
tions at rest. After 2 min of the warm-up contractions, the 
stimulation protocol was initiated. The stimulation protocol 
consisted of one 5-s MVC with doublet delivered over the 
isometric plateau (superimposed doublet) and 3-s after the 
MVC (potentiated doublet). Strong verbal encouragement 
was given during the MVCs by a blinded investigator.
Electrical stimuli were applied transcutaneously using 
a constant-current stimulator (model DS7AH, Digitimer, 
Welwyn Garden City, UK). The femoral nerve was stimu-
lated using a monopolar cathode ball electrode (0.5 cm 
diameter) pressed into the femoral triangle. The site of 
stimulation was marked on the skin so that it could be uti-
lized again for the entire stimulation protocol. The anode 
was a 50-cm2 (10 × 5 cm) rectangular electrode (Com-
pex SA, Ecublens, Switzerland) located in the gluteal 
fold opposite to the cathode. During participants’ first 
visit, stimulus intensity was determined by administering 
twitches of progressively increasing current. The optimal 
intensity of stimulation was reached when an increase in 
the stimulation intensity did not induce further increase 
in the amplitude of the twitch torque and the peak-to-peak 
amplitude of the vastus lateralis M-waves. This inten-
sity was further increased by 25% to ensure that it was 
supramaximal and then maintained for paired stimulations 
during the second and third visits. The pulse width was 
1 ms and the interval between stimuli in the doublet (paired 
stimulations) was 10 ms. The interpolated twitch technique 
method was used for determining the voluntary activation 
level (VAL) as follows: VAL (%) = [1 − (superimposed 
doublet amplitude/potentiated doublet amplitude)] × 100. 
A correction was applied to the original equation when the 
superimposed doublet was elicited slightly before or after 
the real maximal voluntary torque. In these cases, volun-
tary activation level was calculated as [1 − (superimposed 
doublet amplitude × voluntary torque level just before the 
superimposed doublet/maximal voluntary torque)/potenti-
ated doublet amplitude] × 100 (Strojnik and Komi 1998).
Statistical analysis
Unless noted otherwise, data are presented as mean ± SD. 
Paired t test was used to compare motivation, time to 
exhaustion, rest values from the neuromuscular assessment 
and end values during the time to exhaustion test for RPE, 
sEMG RMS, HR and SpO2 between placebo and caffeine 
conditions. A two-way repeated measures analysis of vari-
ance (ANOVA) with factors time and condition (placebo 
vs. caffeine) was used for all the other comparisons. The 
6-min isotime period and time to exhaustion test were ana-
lyzed separately, except for the neuromuscular parameters 
which involved three data points for the time factor (rest, 
after the 6-min isotime period, and after exhaustion). For 
the BRUMS subscales, the time factor data points were 
before and after pill ingestion. For lactate accumulation, the 
time factor data points were after the 6-min isotime period 
and after exhaustion. If a significant time × condition inter-
action was revealed, post hoc analysis was conducted using 
paired t tests with Holm–Bonferroni stepwise correction 
method (Holm 1979) to identify the pairwise differences. 
In these cases, P values already adjusted are shown. When 
time × condition interaction was not significant, a signifi-
cant main effect of time was followed up using Bonferroni 
adjustment. Sphericity was tested using Mauchly’s test, and 
in cases of violation the Greenhouse–Geisser correction 
was applied. Effect sizes are reported as cohen’s d for t tests 
and partial eta squared (ƞP
2) for ANOVA. During the time 
to exhaustion tests, the following data points for the vari-
ables RPE, sEMG RMS, HR and SpO2 were compared: (i) 
the value at the first minute for both conditions (placebo vs. 
caffeine); (ii) the value closest to 50% of time to exhaus-
tion for placebo and the value at the same absolute time in 
the caffeine condition; and (iii) the values from the absolute 
time which occurred for both (placebo and caffeine). Thus, 
we obtained three values at the same absolute times in 
both conditions, in addition to the exhaustion values. Due 
to technical problems, one participant was excluded from 
the sEMG RMS and HR analysis. Significance was set at 
P < 0.05 (two-tailed) for all analyses, which were con-
ducted using the Statistical Package for the Social Sciences 
17.0.0 (SPSS Inc., Chicago, IL, USA).
Results
Incremental exercise test in hypoxia
During the incremental exercise test in hypoxia, participants 
achieved, on average, a PPO of 275 ± 38 W and a VO2max 
of 51  ± 5 ml kg−1 min−1. End values of RPE, lactate con-
centration, HR and SpO2 were 18 ± 1, 13 ± 2 mmol l−1, 
179 ± 10 bpm, and 81 ± 5%, respectively.
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Effects of caffeine on motivation and mood
Only 2 of the 7 participants were able to correctly iden-
tify the treatment (caffeine vs. placebo). Success motiva-
tion (caffeine 17.7 ± 6.2, placebo 17.3 ± 5.8) and intrinsic 
motivation (caffeine 9.1 ± 0.9, placebo 9.7 ± 1.9) related 
to the upcoming exercise task did not differ significantly 
between conditions. The BRUMS questionnaire revealed 
a significant time × condition interaction (F(1,6) = 6.34, 
P = 0.045, ƞP2 = 0.51) in the subscale fatigue. Post hoc 
comparisons revealed a significant decrease in subjec-
tive fatigue 1 h after caffeine ingestion (P = 0.031) (Fig. 2). 
The subscale vigor did not present any significant main 
effect or interaction (Fig. 2).
Effect of caffeine on performance during high‑intensity 
cycling exercise in hypoxia
Time to exhaustion (Fig. 3) was significantly longer in 
the caffeine condition (402 ± 137 s) compared to placebo 
(356 ± 112 s) (t(6) = −3.32, P = 0.016, d = 1.26). Indi-
vidual times to exhaustion were longer in the caffeine con-
dition in six of the seven participants (Fig. 3).
Effects of caffeine on perceptual and physiological 
responses during high‑intensity cycling exercise 
in hypoxia
During both the 6-min isotime period and the time to 
exhaustion test, RPE, sEMG RMS and HR increased sig-
nificantly over time (all main effects of time, P < 0.012) 
(Fig. 4). For the 6-min isotime period, we found a signifi-
cant time × condition interaction for RPE (F(5,30) = 2.77, 
P = 0.036, ƞP2 = 0.32). However, post hoc analysis did not 
detect any differences (lowest P value was 0.27 for minute 
3). During the time to exhaustion test, however, RPE was 
significantly lower in the caffeine condition compared to 
placebo (main effect of condition, F(1,6) = 6.81, P = 0.04, 
ƞP
2 = 0.53) (Fig. 4a). During the time to exhaustion, sEMG 
RMS was significantly lower in the caffeine condition com-
pared to placebo (main effect of condition, F(1,5) = 6.77, 
P = 0.048, ƞP2 = 0.58) (Fig. 4b). For HR values, we found 
a significant main effect of condition for both the 6-min iso-
time period (F(1,5) = 10.12, P = 0.024, ƞP2 = 0.67) and the 
time to exhaustion test (F(1,5) = 9.79, P = 0.026, ƞP2 = 0.66) 
(Fig. 4c) with significantly higher values in the caffeine con-
dition compared to placebo. While during the 6-min isotime 
period SpO2 was significantly lower in the caffeine com-
pared to placebo (main effect of condition F(1,5) = 11.57, 
P = 0.019, ƞP2 = 0.70), we found no differences during the 
time to exhaustion test (Fig. 4d). End values for the time 
to exhaustion test were only significantly different for HR, 
which presented higher values for caffeine (185 ± 6 bpm) 
Fig. 2  Effects of caffeine on the 
BRUMS subscales of fatigue 
and vigor. Values are before 
and 1 h after pill ingestion (caf-
feine vs. placebo). *Significant 
reduction (P < 0.05). Data are 



























Time to Exhaustion - Placebo (s)
Fig. 3  Scatterplot of individual times to exhaustion in the caffeine 
condition and in the placebo condition. The points above the identity 
line represent an improved high-intensity cycling exercise perfor-
mance in the caffeine condition compared to placebo 
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Fig. 4  Effects of caffeine on perceptual and physiological responses 
during high-intensity cycling exercise (6-min isotime period and 
time to exhaustion test) in hypoxia. a RPE. b sEMG RMS. c Heart 
rate. d SpO2. *Significant difference between caffeine and pla-
cebo (P < 0.05). #Significant main effect of time (P < 0.05). †Sig-
nificant main effect of condition (P < 0.05). $Significant interaction 
(P < 0.05). Data are presented as mean ± SEM
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than placebo (179 ± 7 bpm) (t(5) = −4.58, P = 0.006, 
d = 1.87). Lactate accumulation increased over time (main 
effect of time, F(1,6) = 32.73, P = 0.001, ƞP2 = 0.85) with no 
significant main effect of condition. Values for placebo and 
caffeine conditions were 7.5 ± 3.3 vs. 8.8 ± 2.3 mmol l−1 
after the 6-min isotime period and 10.5 ± 1.6 vs. 
12.74 ± 2.4 mmol l−1 after the time to exhaustion test, 
respectively.
Effects of caffeine on neuromuscular fatigue induced 
by high‑intensity cycling exercise in hypoxia
A typical trace from one participant is illustrated in Fig. 5. 
MVC torque (F(2,12) = 8.08, P = 0.006, ƞP2 = 0.57), dou-
blet (F(2,12) = 21.97, P < 0.001, ƞP2 = 0.79) and VAL 
(F(2,12) = 5.15, P = 0.024, ƞP2 = 0.46) presented a signifi-
cant main effect of time (Fig. 6). MVC torque decreased by 
13.4 ± 17.5 and 14.1 ± 19.7% from rest to isotime, and by 
16.0 ± 16.6 and 21.4 ± 17.7% from rest to exhaustion in 
the placebo and caffeine conditions, respectively. Follow-
up tests revealed significant reductions in MVC torque only 
from rest to exhaustion (P < 0.05). Doublet decreased by 
16.2 ± 11.0 and 15.9 ± 16.6% from rest to isotime, and 
by 24.3 ± 10.5 and 26.4 ± 22.0% from rest to exhaus-
tion in the placebo and caffeine conditions, respectively. 
Follow-up tests revealed significant reductions in doublet 
from rest to isotime (P < 0.05) and from rest to exhaus-
tion (P < 0.01). Lastly, VAL decreased by 0.0 ± 3.0 and 
2.7 ± 4.4% from rest to isotime, and by 3.0 ± 2.3 and 
3.8 ± 5.1% from rest to exhaustion in the placebo and caf-
feine conditions, respectively. Follow-up tests revealed 
significant reductions in VAL only from rest to exhaustion 
(P < 0.01). Absolute values are presented in Fig. 6. 
Discussion
The main finding of this study is that the effect of caffeine 
on performance during high-intensity cycling exercise in 
moderate hypoxia does not seem to be associated with a 
significant reduction in neuromuscular fatigue. In fact, con-
trary to our hypotheses, the MVC loss, central fatigue and 
peripheral fatigue induced by high-intensity cycling exer-
cise in moderate hypoxia measured 3 min after exhaus-
tion were not reduced by caffeine ingestion. Our study 
was the second to measure the effects of caffeine on these 
neuromuscular parameters before and after dynamic exer-
cises in hypoxia and, therefore, comparisons are difficult. 
Eaton et al. (2016), the only other study with a similar test-
ing protocol, did not find any difference in neuromuscular 
parameters (MVC and twitch torque, and central activa-
tion ratio) when comparing the caffeine only and placebo 
conditions after an exercise task designed to mimic the 
running profile of team sport athletes. This study, which 
involved other conditions such as caffeine plus essential 
amino acids, presented a few moderating factors such as 
heat (30 °C) and prior ingestion of carbohydrates in addi-
tion to hypoxia (Eaton et al. 2016). Utilizing a similar test-
ing protocol in normoxia, Black et al. (2015) investigated 
the effects of caffeine (5 mg kg−1) on MVC loss, central 
fatigue and peripheral fatigue after both arm and leg cycling 
exercise with a period of 30 min at a constant intensity 
(60% VO2max), followed by a 10-min time trial. Similar to 
our results, they found that caffeine reduced perception of 
effort and pain, and improved performance despite no effect 
on neuromuscular fatigue when compared to placebo. It is 
noteworthy, however, that neuromuscular assessments were 
Fig. 5  Original torque record-
ings from one participant 
related to the measurements of 
central (superimposed doublet 
over the maximal voluntary 
contraction) and peripheral 
(potentiated doublet at rest) 
fatigue, both before the exercise 
task and after exhaustion
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made only 20 min after time-trial completion (Black et al. 
2015). Interestingly, in their additional study, Black et al. 
(2015) found no differences in perception of effort, pain 
and time to exhaustion at exercise intensities closer to the 
ones used in the present study after caffeine ingestion. This 
is unexpected, since the literature has shown a rather con-
sistent effect of caffeine on perception of effort (Doherty 
et al. 2004; Doherty and Smith 2005) and on endurance 
performance (Doherty and Smith 2004; Astorino and Rob-
erson 2010). The only other study investigating the effects 
of caffeine on neuromuscular fatigue during dynamic exer-
cise reported some contrasting results (Cureton et al. 2007). 
Caffeine improved performance during the exercise task 
(cycling 120 min between 60 and 75% VO2max + 15-min 
time trial) and attenuated the MVC loss measured 20 min 
after exercise termination, as well as avoided the develop-
ment of peripheral fatigue, assessed 7.5 min after exercise 
termination. However, as also acknowledged by the authors 
(Cureton et al. 2007), it is difficult to isolate the ergogenic 
effects of caffeine on neuromuscular fatigue, as the caf-
feine condition also included ingestion of CHO, taurine, 
carnitine, vitamins and sucralose. In addition, it is difficult 
to distinguish between the effects of these substances on 
fatigue development or on the recovery process, given the 
long recovery time between exercise termination and neu-
romuscular assessment.
Our sEMG RMS data from the vastus lateralis revealed 
a significantly lower sEMG amplitude in the caffeine con-
dition during the time to exhaustion test, but not during the 
6-min isotime period, in the caffeine condition when com-
pared to placebo despite being performed at the same abso-
lute power output and pedaling cadence (Fig. 4b). However, 
as central and peripheral fatigue did not differ between 
conditions, these results are difficult to explain. When neu-
romuscular fatigue (central and peripheral fatigue) is unal-
tered, no difference in sEMG amplitude during exercise is 
expected. Although we have not normalized sEMG RMS 
data by the maximal M-wave (see “Limitations”), two stud-
ies involving mental fatigue confirmed this expectation 
(Pageaux et al. 2013; Rozand et al. 2014), while another 
study found a dissociation between sEMG amplitude and 
neuromuscular fatigue (Pageaux et al. 2015), similar to 
our results. A speculative hypothesis may be an alteration 
in motor control between conditions (placebo vs. caffeine) 
after certain degree of fatigue occurred during the time to 
exhaustion test (Budini et al. 2014). However, a measure of 
muscle co-activation (e.g., biceps femoris) would be neces-
sary to strengthen this hypothesis. In addition, the lack of 
normalization of the sEMG RMS data by the M-waves, as 
well as measurement of sEMG and neuromuscular fatigue 
in different conditions (exercise in hypoxia vs. after exer-
cise in normoxia, respectively), further complicates this 
interpretation.
Despite no positive effects on neuromuscular fatigue, 
caffeine led to a significant 12% improvement in time to 
exhaustion during high-intensity cycling exercise in condi-
tions of moderate hypoxia equivalent to 2500 m altitude. 
This finding corroborates previous studies on the ergogenic 
effect of caffeine on endurance performance in hypoxia. 
Stadheim et al. (2015) found that caffeine increases time to 
exhaustion during a high-intensity double poling exercise 
by 20% at a simulated altitude of 2000 m above sea level. 
With a high-intensity cycling test similar to ours, Fulco 
et al. (1994) found a significant 54% improvement in time 
to exhaustion after caffeine ingestion in conditions of acute 
Fig. 6  Effects of caffeine on neuromuscular fatigue induced by high-
intensity cycling exercise (after the 6-min isotime period and after 
the time to exhaustion test) in hypoxia. a MVC. b Peripheral fatigue 
(doublet). c Central fatigue (VAL). #Significant main effect of time 
(P < 0.05). ªSignificant difference from the rest value (P < 0.05). Data 
are presented as mean ± SEM
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hypoxia at an altitude of 4300 m above sea level. With 
regard to time-trial performance, Berglund and Hemmings-
son (1982) studied cross-country skiers at 2900 m and 
found that caffeine induces a significant 1.7% reduction 
in performance time during a 21-km time trial. In a more 
recent investigation of cross-country skiers, Stadheim et al. 
(2015) found that caffeine induces a non-significant 0.9% 
reduction in performance time during a double poling 8-km 
time trial at a simulated altitude of 2000 m above sea level.
The most likely explanation for enhanced endurance 
performance in hypoxic conditions is the reduction in per-
ception of effort induced by caffeine (Fig. 4a). Such per-
ceptual effect of caffeine has been previously observed in 
both normoxia (Doherty et al. 2004; Doherty and Smith 
2005) and hypoxia (Berglund and Hemmingsson 1982; 
Fulco et al. 1994; Stadheim et al. 2015), and it is consid-
ered one of the main mechanisms through which caffeine 
improves endurance performance in normoxia (Doherty 
and Smith 2005). These findings fit with the psychobio-
logical model of endurance performance (Smirmaul et al. 
2013). This model postulates that exhaustion is not directly 
caused by neuromuscular fatigue but rather by a decision-
making process based on perception of effort and potential 
motivation (defined as the maximum effort one is willing to 
exert in order to succeed in the task) (Marcora et al. 2008; 
Marcora and Staiano 2010; Smirmaul et al. 2013). There-
fore, any intervention that reduces perception of effort 
and/or increase potential motivation should increase time 
to exhaustion even in the absence of a significant reduc-
tion in neuromuscular fatigue. Similar scores for RPE at 
exhaustion and the motivation scales suggest that caffeine 
did not increase potential motivation. However, the likely 
lower RPE during the 6-min isotime period (significant 
time × condition interaction, but no significant differ-
ences detected by the post hoc analysis, see “Results” sec-
tion) and during the time to exhaustion test (significant 
main effect of condition) shows that perception of effort 
was likely reduced by caffeine ingestion, with consequent 
delay of the time at which most participants reached their 
perceived maximal effort and decided to stop exercising 
(Fig. 4a). The present study design, however, employed a 
5-min rest followed by a wash-in period of 5-min breathing 
hypoxic air after the neuromuscular assessments (between 
the 6-min isotime period and the time to exhaustion test), 
and it is difficult to assure that the starting states of the neu-
romuscular parameters for the time to exhaustion test were 
similar between conditions. If fatigue had better recovered 
in the caffeine condition during this recovery period, the 
lower RPE may have reflected the lower extent of neuro-
muscular fatigue. In addition, as our peripheral fatigue 
results did not demonstrate differences between condi-
tions despite increased time to exhaustion after caffeine 
ingestion, other theoretical models such as the “critical 
peripheral fatigue threshold model” (Amann et al. 2013) 
cannot be discarded as an alternative explanation for the 
ergogenic effect of caffeine. However, there is evidence 
that a critical peripheral fatigue threshold does not limit 
endurance performance (Smirmaul and Dantas 2011; John-
son et al. 2015).
Although measured at different time points and envi-
ronmental conditions (after exercise in hypoxia vs. at rest 
in normoxia), neuromuscular fatigue occurred to a similar 
extent in the caffeine and placebo conditions. Thus, the 
observed reduction in perception of effort after caffeine 
ingestion is not likely to be explained by a reduction in the 
central motor command required to compensate for neuro-
muscular fatigue (DeMorree et al. 2012). Instead, the caf-
feine-induced reduction in perception of effort may result 
from a direct effect of caffeine on the brain that can reduce 
the activity of premotor and/or motor areas of the cortex 
even when force output stays constant (DeMorree et al. 
2014). A direct effect of caffeine on the brain of our partici-
pants is indirectly corroborated by the significant effect of 
caffeine on subjective fatigue measured at rest via a mood 
questionnaire (Fig. 2). In addition, caffeine increased HR, 
an effect commonly observed during exercise in normoxia 
and corroborated in hypoxia (Stadheim et al. 2015). While 
SpO2 did not differ between conditions during the time to 
exhaustion test, an unexpected finding was its reduction 
during the 6-min isotime period after caffeine ingestion. 
This results is contrary to previous findings showing a caf-
feine-induced  increase in SpO2 during similar submaximal 
exercise intensities (Chapman and Mickleborough 2009). 
However, how these caffeine-induced effects on HR, SpO2 
and ventilation (not measured in the present study) interact 
to positively or negatively influence respiratory effort and 
endurance performance at altitude is currently unknown 
(please refer to Chapman and Mickleborough 2009). 
Lastly, while the literature has shown mixed results on the 
effects of caffeine on lactate concentrations (Davis and 
Green 2009), we found no effect of caffeine ingestion on 
lactate accumulation.
Limitations
A few limitations need to be taken into account in evalu-
ating the present study. First, voluntary activation was 
assessed during an isometric MVC of the knee exten-
sor muscles, which is a different task from cycling. This 
may have precluded detection of all the specific fatigue 
processes induced by high-intensity cycling exercise in 
moderate hypoxia. Second, neuromuscular assessment 
was performed 3 min after exhaustion, which may have 
led to an underestimation of the extent of neuromuscular 
fatigue-induced high-intensity cycling exercise in moder-
ate hypoxia (Froyd et al. 2013). However, using a similar 
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recovery period, previous studies were still able to find dif-
ferences in the extent of neuromuscular fatigue (Amann 
et al. 2006; Goodall et al. 2012). Furthermore, a study 
involving cycling exercise performed in similar conditions 
of moderate hypoxia (FIO2 = 0.15) has shown that neu-
romuscular fatigue does not recover within 1–4 min after 
exercise termination (Dahlstrom et al. 2013). Third, we did 
not measure M-waves during the experimental visits, not 
allowing for normalization of the sEMG RMS data to the 
M-waves and limiting our control over possible changes in 
neuromuscular junction and sarcolemma excitation. Fourth, 
although all procedures were performed in a similar way 
for both conditions (placebo × caffeine), we assessed neu-
romuscular fatigue parameters in normoxia. This study 
design has been used previously in studies of neuromuscu-
lar fatigue during high-intensity cycling exercise in hypoxia 
(Amann et al. 2006; Romer et al. 2007). However, it is not 
possible to rule out a potential recovery from the specific 
effects of hypoxia. Lastly, the lack of respiratory variables 
limits our understanding of the SpO2 results, and future 
investigations may further investigate this issue.
Conclusion
The positive effect of caffeine on high-intensity cycling 
exercise performance in moderate hypoxia seems to be 
mediated by the caffeine-induced reduction in perception 
of effort and improved mood, rather than reduced neu-
romuscular fatigue. These findings provide preliminary 
information to physiologists regarding the mechanisms 
underlying the ergogenic effect of caffeine during exer-
cise in hypoxic conditions. They also provide further 
evidence to coaches, athletes, mountaineers and soldiers 
operating at high altitude that caffeine supplementation 
may reduce, in part, the negative effects of hypoxia on 
perception of effort and endurance performance.
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